| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 28.13▼ | 28.13▼ | 28.13▼ | 28.09▲ | 28.58▼ |
| MA10 | 28.13▼ | 28.14▼ | 28.17▼ | 28.27▼ | 28.63▼ |
| MA20 | 28.14▼ | 28.35▼ | 28.39▼ | 28.41▼ | 28.25▼ |
| MA50 | 28.64▼ | 28.83▼ | 28.74▼ | 28.48▼ | 26.95▲ |
| MA100 | 28.62▼ | 28.38▼ | 28.23▼ | 28.16▼ | N/A |
| MA200 | 27.81▲ | N/A | N/A | 27.18▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.026▲ | -0.001▼ | -0.018▼ | -0.048▼ | -0.082▼ |
| RSI | 38.329▼ | 38.868▼ | 40.093▼ | 46.019▼ | 52.258▲ |
| STOCH | 56.309 | 30.095 | 30.804 | 24.998 | 55.261 |
| WILL %R | -100.000▼ | -85.882▼ | -74.490 | -66.667 | -61.242 |
| CCI | -100.000▼ | -92.780 | -70.487 | -76.847 | -39.157 |
|
Tuesday, November 25, 2025 11:43 AM
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the immuno-oncology industry, including Exact Sciences (NASDAQ:EXAS) and its peers. Over the next few years, ...
|
|
Monday, November 03, 2025 02:00 PM
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported in Q3 CY2025, with sales up 20% year on year to $850.7 million. The company’s full-year revenue guidance of $3.23 billion at the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/10/26 | 28.14 | 28.18 | 27.94 | 28.15 | 4,178 |
| 01/10/26 | 27.93 | 27.93 | 27.70 | 27.825 | 7,580 |
| 30/09/26 | 28.15 | 28.16 | 28.0122 | 28.0122 | 3,074 |
| 29/09/26 | 28.17 | 28.3499 | 28.10 | 28.235 | 18,025 |
| 28/09/26 | 28.12 | 29.04 | 28.10 | 28.22 | 3,563 |
| 25/09/26 | 28.32 | 28.545 | 28.32 | 28.505 | 3,503 |
| 24/09/26 | 28.15 | 28.26 | 27.95 | 28.15 | 8,255 |
| 23/09/26 | 28.47 | 28.47 | 28.208 | 28.215 | 3,981 |
| 22/09/26 | 28.68 | 28.69 | 28.53 | 28.69 | 1,562 |
| 21/09/26 | 28.51 | 28.925 | 28.455 | 28.7249 | 3,625 |
|
|
||||
|
|
||||
|
|